CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-14 | WILSON JAMES N Director | Sale 10b5-1 | −4,668 | $111.44 | $520K | 1,076,822 |
| 2026-08-14 | WILSON JAMES N Director | Sale 10b5-1 | −2,279 | $112.64 | $257K | 1,074,543 |
| 2026-08-12 | Robb Gary Charles Chief Business Officer | Gift | −11,530 | 13,551 | ||
| 2026-08-12 | Robb Gary Charles Chief Business Officer | Gift | +3,000 | 15,571 | ||
| 2026-08-12 | Robb Gary Charles Chief Business Officer | Gift | +3,000 | 15,571 | ||
| 2026-08-10 | Maduck Sean See Remarks | Option exercise 10b5-1 | +1,031 | $8.27 | $9K | 10,786 |
| 2026-08-10 | Maduck Sean See Remarks | Sale 10b5-1 | −1,031 | $114.52 | $118K | 9,755 |
| 2026-08-10 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −1,031 | 95,650 | ||
| 2026-08-10 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +16,300 | $21.65 | $353K | 20,285 |
| 2026-08-10 | Guyer William Chief Development Officer | Sale 10b5-1 | −11,530 | $113.18 | $1.3M | 8,755 |
| 2026-08-10 | Guyer William Chief Development Officer | Sale 10b5-1 | −4,770 | $114.04 | $544K | 3,985 |
| 2026-08-10 | Guyer William Chief Development Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −16,300 | 110,000 | ||
| 2026-08-04 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +3,700 | $21.65 | $80K | 7,685 |
| 2026-08-04 | Guyer William Chief Development Officer | Sale 10b5-1 | −3,700 | $113.12 | $419K | 3,985 |
| 2026-08-04 | Guyer William Chief Development Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −3,700 | 126,300 | ||
| 2026-08-03 | Maduck Sean See Remarks | Option exercise 10b5-1 | +20,305 | $8.27 | $168K | 30,060 |
| 2026-08-03 | Maduck Sean See Remarks | Sale 10b5-1 | −20,305 | $114.70 | $2.3M | 9,755 |
| 2026-08-03 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −20,305 | 96,681 | ||
| 2026-08-03 | Lyon Joseph Douglas See Remarks | Sale | −1,540 | $114.16 | $176K | 5,495 |
| 2026-07-30 | Mokari Atabak Chief Financial Officer | Option exercise 10b5-1 | +80,000 | $23.06 | $1.8M | 96,130 |
Page 6 of 50 · 995 trades